DC-CIK TREATMENT

Clinical trials for DC-CIK TREATMENT explained in plain language.

Never miss a new study

Get alerted when new DC-CIK TREATMENT trials appear

Sign up with your email to follow new studies for DC-CIK TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Three-Pronged attack on Tough-to-Treat colon cancer

Disease control Recruiting now

This early-stage study is testing a new three-part treatment for advanced colorectal cancer that has stopped responding to standard therapies. It combines an immunotherapy drug, a targeted cancer drug, and a personalized cell therapy made from the patient's own immune cells. The …

Matched conditions: DC-CIK TREATMENT

Phase: EARLY_PHASE1 • Sponsor: JIANG LONGWEI • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

DC-CIK TREATMENT

Get alerted when new DC-CIK TREATMENT trials appear

Three-Pronged attack on Tough-to-Treat colon cancer